Paul Gabos Net Worth

The estimated Net Worth of Paul G Gabos is at least $1.24 Million dollars as of 5 March 2020. Mr. Gabos owns over 20,000 units of Pediatrix Medical Inc stock worth over $1,022,613 and over the last 16 years he sold MD stock worth over $0. In addition, he makes $220,005 as Independent Director at Pediatrix Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Gabos MD stock SEC Form 4 insiders trading

Paul has made over 9 trades of the Pediatrix Medical Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently he exercised 20,000 units of MD stock worth $234,600 on 5 March 2020.

The largest trade he's ever made was exercising 44,000 units of Pediatrix Medical Inc stock on 10 November 2009 worth over $1,078,440. On average, Paul trades about 4,311 units every 111 days since 2009. As of 5 March 2020 he still owns at least 96,382 units of Pediatrix Medical Inc stock.

You can see the complete history of Mr. Gabos stock trades at the bottom of the page.

Paul Gabos biography

Paul G. Gabos serves as Independent Director of the Company. Mr. Gabos, who is presently retired, served as Chief Financial Officer of Lincare Holdings Inc. (“Lincare”), a provider of oxygen and other respiratory therapy services to patients in the home, from June 1997 until December 2012, after its merger with a subsidiary of Linde AG, and prior thereto served as Vice President — Administration for Lincare. Prior to joining Lincare in 1993, Mr. Gabos worked for Coopers & Lybrand, an accounting firm, prior to its merger with Price Waterhouse, and for Dean Witter Reynolds, Inc., a securities firm. Mr. Gabos currently serves as Chairman of the Board of Directors of Benefytt Technologies, Inc. The Board of Directors has concluded that Mr. Gabos’ qualifications to serve on the Board include his management experience as a senior executive and financial expertise as Chief Financial Officer of a publicly traded healthcare services company and prior thereto as an investment banker with a large national firm.

What is the salary of Paul Gabos?

As the Independent Director of Pediatrix Medical Inc, the total compensation of Paul Gabos at Pediatrix Medical Inc is $220,005. There are 11 executives at Pediatrix Medical Inc getting paid more, with Roger Medel having the highest compensation of $8,066,280.

How old is Paul Gabos?

Paul Gabos is 55, he's been the Independent Director of Pediatrix Medical Inc since 2002. There are 10 older and 9 younger executives at Pediatrix Medical Inc. The oldest executive at Pediatrix Medical Group Inc is Dr. Roger J. Medel, 74, who is the Co-Founder & Director.

What's Paul Gabos's mailing address?

Paul's mailing address filed with the SEC is 1301, Concord Terrace, Sunrise, Broward County, Florida, 33323, United States.

Insiders trading at Pediatrix Medical Inc

Over the last 16 years, insiders at Pediatrix Medical Inc have traded over $151,130,633 worth of Pediatrix Medical Inc stock and bought 737,264 units worth $19,901,767 . The most active insiders traders include Roger Md Medel, Manuel Kadre, and Michael Fernandez. On average, Pediatrix Medical Inc executives and independent directors trade stock every 25 days with the average trade being worth of $297,048. The most recent stock trade was executed by James D Swift on 30 August 2024, trading 11,100 units of MD stock currently worth $119,769.

What does Pediatrix Medical Inc do?

mednax is a physician-led health solutions partner providing the highest quality patient care through our national network of nearly 3,000 physicians. our physician practices and business professionals are passionate about taking great care of patients, continually optimizing performance and helping providers overcome healthcare’s quality, financial and administrative complexities. physicians and advanced practitioners practicing as part of mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research to enhance patient outcomes and provide high-quality, cost-effective care. the company was founded in 1979, and today, through its affiliated professional corporations, mednax provides services through a network of more than 3,200 physicians in all 50 states and puerto rico. in addition to its national physician network, mednax provides services to healthcare facilities and physicians in

Complete history of Mr. Gabos stock trades at Health Insurance Innovations and Pediatrix Medical Inc

Pediatrix Medical Inc executives and stock owners

Pediatrix Medical Inc executives and other stock owners filed with the SEC include:

• Roger Medel,
  Director
• John Pepia,
  Senior Vice President, Chief Accounting Officer
• Dominic Andreano,
  Executive Vice President, General Counsel, Secretary
• Dr. Roger J. Medel,
  Co-Founder & Director
• Mark S. Ordan,
  CEO & Director
• Dr. Roger Mack Hinson M.D.,
  Pres of Pediatrix & Obstetrix Medical Groups
• Dominic J. Andreano,
  Exec. VP, Gen. Counsel & Sec.
• John C. Pepia,
  Sr. VP & Chief Accounting Officer
• C. Marc Richards,
  Exec. VP, CFO & Principal Accounting Officer
• Michael Rucker,
  Independent Director
• Manuel Kadre,
  Lead Independent Director
• Paul Gabos,
  Independent Director
• Waldemar Carlo,
  Independent Director
• Karey Barker,
  Independent Director
• Charles Lynch,
  Vice President, Strategy and Investor Relations
• Shirley Weis,
  Independent Director
• John Starcher,
  Independent Director
• Thomas McEachin,
  Independent Director
• Nikos Nikolopoulos,
  Executive Vice President, Chief Strategy and Growth Officer
• C. Marc Richards,
  Chief Financial Officer, Executive Vice President
• Mark Ordan,
  Chief Executive Officer
• Guy Sansone,
  Independent Chairman of the Board
• Claire M. Fair,
  Sr. VP & Chief HR Officer
• Dr. James D. Swift M.D.,
  Chief Devel. Officer
• Dana Dreher-Rodwell,
  VP & Chief Compliance Officer
• Charles W. Lynch C.F.A.,
  Sr. VP of Fin., Strategy & Investor Relations
• Sylvia Jean Young,
  
• Donna E Shalala,
  Director
• Cesar L Alvarez,
  Director
• Michael D Stanley,
  President, Pediatrix Division
• Karl B Wagner,
  Chief Financial Officer
• Md Pascal J Goldschmidt,,
  Director
• Enrique Sosa,
  Director
• Vivian Lopez Blanco,
  Chief Financial Officer
• Michael Fernandez,
  Director
• Nicholas J Nikolopoulos,
  EVP Chf Strategy & Growth Offi
• David A. Clark,
  Chief Operating Officer
• Joseph M Calabro,
  President and COO
• Laura A Linynsky,
  
• Roger K Freeman,
  Director
• William C Hawk,
  COO American Anesthesiology
• Thomas W Hawkins,
  SVP, General Counsel and Secy.
• Frederick V Miller,
  President, Pediatrix Division
• Dany Garcia,
  Director
• Carlos A Migoya,
  Director
• Stephen D Farber,
  Former Chief Financial Officer
• Roger Mack Hinson,
  Pres., PDX & OBX Medical Group
• Mary Ann E Moore,
  EVP, General Counsel & Sec
• Curtis Pickert,
  EVP, Chief Operating Officer
• James D Swift,
  Chief Executive Officer
• Lee Wood,
  EVP, Natl & Market Operations